Syndax Pharmaceuticals, Inc.SNDXNASDAQ
LOADING
|||
EV to Sales: Discounted Valuation
Below historical average.
Left:
||||
Enterprise value to sales ratio
Latest
55.89
↓ 46% below average
Average (9y)
102.58
Historical baseline
Range
High:543.17
Low:0.00
CAGR
-2.5%
Modest growth trend
| Period | Value | Change |
|---|---|---|
| 2024 | 55.89 | - |
| 2023 | 0.00 | - |
| 2022 | 0.00 | -100.0% |
| 2021 | 6.72 | -98.8% |
| 2020 | 543.17 | +237.7% |
| 2019 | 160.84 | +208.3% |
| 2018 | 52.16 | -26.1% |
| 2017 | 70.57 | +6.3% |
| 2016 | 66.38 | -5.3% |
| 2015 | 70.06 | - |